Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?

Avraham Beigelman; Leonard B. Bacharier; Jack Baty; Richard Buller; Sheila Mason; Kenneth B. Schechtman; Geneline Sajol; Megan Isaacson-Schmid; Mario Castro; Gregory A. Storch

doi:10.1016/j.jaci.2015.06.011

Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?

Avraham Beigelman, Leonard B. Bacharier, Jack Baty, Richard Buller, Sheila Mason, Kenneth B. Schechtman, Geneline Sajol, Megan Isaacson-Schmid, Mario Castro, Gregory A. Storch

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	1129-1131
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	136
Issue number	4
DOIs	https://doi.org/10.1016/j.jaci.2015.06.011
State	Published - Oct 2015

Access to Document

10.1016/j.jaci.2015.06.011

Cite this

Beigelman, Avraham ; Bacharier, Leonard B. ; Baty, Jack ; Buller, Richard ; Mason, Sheila ; Schechtman, Kenneth B. ; Sajol, Geneline ; Isaacson-Schmid, Megan ; Castro, Mario ; Storch, Gregory A. / Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?. In: Journal of Allergy and Clinical Immunology. 2015 ; Vol. 136, No. 4. pp. 1129-1131.

@article{5251a1d42d8e4274945666b7589e4964,

title = "Does azithromycin modify viral load during severe respiratory syncytial virus bronchiolitis?",

author = "Avraham Beigelman and Bacharier, {Leonard B.} and Jack Baty and Richard Buller and Sheila Mason and Schechtman, {Kenneth B.} and Geneline Sajol and Megan Isaacson-Schmid and Mario Castro and Storch, {Gregory A.}",

note = "Funding Information: This study was supported by the Washington University Institute of Clinical and Translational Sciences (grant no. UL1 TR000448 from the National Center for Advancing Translational Sciences , subaward KL2 TR000450) and the Children's Discovery Institute of Washington University and St Louis Children's Hospital . This study was supported in part (REDCap database) by the National Institutes of Health's Clinical and Translational Science Award (CTSA) (grant no. UL1 TR000448 ) and the Siteman Comprehensive Cancer Center and the National Cancer Institute (NCI) Cancer Center (support grant no. P30 CA091842 ). Funding Information: Disclosure of potential conflict of interest: L. B. Bacharier has received research support from the National Institutes of Health (NIH) and from National Heart, Lung, and Blood Institute/NIH AsthmaNet and has received consultancy fees from Aerocrine, AstraZeneca, Genentech/Novartis, GlaxoSmithKline, Merck, Schering, and Teva. M. Castro has received grants from the NIH during the conduct of the study; personal fees from Asthmatx/Boston Scientific, IPS/Holaria, Genentech, Merck, GSK, Genentech, Boehringer-Ingelheim, and Elsevier; grants from Boston Scientific, Amgen, Ception/Cephalon/Teva, Genetech, Medimmune, Merck, Novartis, GSK, Sanofi-Aventis, Vectura, NextBio, and KalaBios; and stock options from Sparo, Inc, all outside the submitted work. The rest of the authors have received research support from the NIH. ",

year = "2015",

month = oct,

doi = "10.1016/j.jaci.2015.06.011",

language = "English",

volume = "136",

pages = "1129--1131",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

number = "4",

}